Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program

Journal of Infusion Nursing

Volumn 37, Issue 1, 2014, Pages 29-34

  Gregory, Cherylann ^a   Landmesser, Ladonna M ^b   Corrigan, Larry ^b   Mariano, David ^b  

^a Specialty Pharmacy Nursing Network Inc   (United States)

^b ViroPharma Incorporated   (United States)

Author keywords

C1 esterase inhibitor; Cinryze; Hereditary angioedema; Home administration; Home infusion; Nursing program; Self administration; Training program

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; DRUG INFUSION; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE FACILITY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NURSE TRAINING; PRIORITY JOURNAL; PROGRAM FEASIBILITY; SCHOOL CHILD; YOUNG ADULT; AGED; ANGIOEDEMAS, HEREDITARY; FEASIBILITY STUDY;

ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEASIBILITY STUDIES; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; SELF ADMINISTRATION; YOUNG ADULT;

EID: 84893345235     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0000000000000018     Document Type: Article

References (23)

1. Gompels MM, Lock RJ. C1 inhibitor deficiency: diagnosis. Clin Exp Dermatol. 2005; 30 ( 4 ): 460-462.
2. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008; 359 ( 10 ): 1027-1036.
3. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976; 84 ( 5 ): 580-593.
4. Bork K, Ressel N. Sudden upper airway obstruction in patients with hereditary angioedema. Transfus Apher Sci. 2003; 29 ( 3 ): 235-238.
5. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012; 130 ( 3 ): 692-697.
6. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010; 31 ( 5 ): 407-414.
7. Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol. 2009; 19 ( 2 ): 147-151.
8. Kreuz W, Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Heller C, Klingebiel T. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion. 2012; 52 ( 1 ): 100-107.
9. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006; 117 ( 4 ): 904-908.
10. Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL. Safety and efficacy of physician-supervised selfmanaged C1 inhibitor replacement therapy. Int Arch Allergy Immunol. 2012; 157 ( 4 ): 417-424.
11. Longhurst HJ, Farkas H, Craig T, et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol. 2010; 6 ( 1 ): 22.
12. Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012; 35 ( 2 ): 84-91.
13. Rabiner SF, Telfer MC, Fajardo R. Home transfusions of hemophiliacs. JAMA. 1972; 221 ( 8 ): 885-887.
14. Johansson E, Langius-Eklof A, Engervall P, Wredling R. Patients' experience of ambulatory self-administration of pamidronate in multiple myeloma. Cancer Nurs. 2005; 28 ( 2 ): 158-165.
15. Cousins A, Lee P, Rorman D, et al. Home-based infusion therapy for patients with Fabry disease. Br J Nurs. 2008; 17 ( 10 ): 653-657.
16. Linthorst GE, Vedder AC, Ormel EE, Aerts JM, Hollak CE. Home treatment for Fabry disease: practice guidelines based on 3 years experience in The Netherlands. Nephrol Dial Transplant. 2006; 21 ( 2 ): 355-360.
17. Ochs HD, Fischer SH, Lee ML, Delson ES, Kingdon HS, Wedgwood RJ. Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases. Lancet. 1986; 1 ( 8481 ): 610-611.
18. Winter RJ, George RJ, Deacock SJ, Shee CD, Geddes DM. Selfadministered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet. 1984; 1 ( 8390 ): 1338-1339.
19. Van Eys J, Lilly-McKenzie LC. Hemophilia home administration. A report on two years' experience. J Tenn Med Assoc. 1973; 66 ( 12 ): 1131-1133.
20. Bhole MV, Burton J, Chapel HM. Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy. Immunol Allergy Clin North Am. 2008; 28 ( 4 ): 821-832, ix.
21. Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, Fischer K. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia. 2012; 18 ( 4 ): 516-520.
22. Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia. 2001; 7 ( 4 ): 392-396.
23. Berntorp E. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens. Haemophilia. 2009; 15 ( 6 ): 1219-1227.